Citation Impact
Citing Papers
Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus
2012
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody
2018
Vildagliptin: a new oral treatment for type 2 diabetes mellitus
2008
Managing Type 2 Diabetes: Balancing HbA1cand Body Weight
2010
ROS in cancer therapy: the bright side of the moon
2020 Standout
Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A
2020
Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study
2012 Standout
Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review
2010
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Type 2 diabetes mellitus
2015 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Bispecific antibodies: a mechanistic review of the pipeline
2019
Glycaemic control in type 2 diabetes: Targets and new therapies
2009
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
2021 StandoutNobel
Dipeptidyl peptidase‐4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta‐analysis of randomized controlled trials
2011
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Green synthesis of zinc oxide nanoparticles using Hibiscus subdariffa leaf extract: effect of temperature on synthesis, anti-bacterial activity and anti-diabetic activity
2014 Standout
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Modular repeat protein sculpting using rigid helical junctions
2020 StandoutNobel
Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation
2010
Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials
2014
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Pharmaceuticals that contain polycyclic hydrocarbon scaffolds
2015
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Works of Markus Niggli being referenced
Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24‐week, double‐blind, randomized trial
2008
Long‐term 2‐year safety and efficacy of vildagliptin compared with rosiglitazone in drug‐naïve patients with type 2 diabetes mellitus
2009
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
2018